Calls For Flexibility To All ‘Game Changing’ Cancer Treatments
Sarcoma UK is calling on the National Institute for Health and Care Excellence (NICE), NHS England, and pharmaceutical companies to…
Sarcoma UK is calling on the National Institute for Health and Care Excellence (NICE), NHS England, and pharmaceutical companies to…
- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system - Findings underline importance of…
· Only 28 per cent of people believe cancers can be controlled long term – yet the average patient now…
Sarcoma UK is disappointed to see that life extending cancer drug trabectedin (Yondelis) will not be made available routinely on…
A comprehensive new report launched on Tuesday 26th November 2019 and commissioned by the charity Sarcoma UK reveals how this…
Researchers at Queen’s University Belfast have received the first scientific research grant from MDS UK to improve treatment for Myelodysplastic…
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy…
If Bal Gill had not chosen to visit the Camera Obscura and World of Illusions at Edinburgh’s Royal Mile earlier…
It is a while since I have written a blog. My disease has been stable for just over a year…
New data will offer a unique insight into whether prostate MRI could be the test that we are looking for…
This website uses cookies.